A detailed history of Allianz Asset Management Gmb H transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 16,700 shares of PCRX stock, worth $320,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,700
Holding current value
$320,640
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$11.7 - $28.46 $195,390 - $475,282
16,700 New
16,700 $251,000
Q2 2017

Aug 14, 2017

SELL
N/A
-21,100 Closed
0 $0
Q1 2017

Apr 17, 2019

SELL
N/A
-32,037 Reduced 60.29%
21,100 $962,000
Q3 2016

Apr 17, 2019

BUY
N/A
53,137
53,137 $1.82 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $880M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.